<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03629353</url>
  </required_header>
  <id_info>
    <org_study_id>THRIVE during LMS</org_study_id>
    <nct_id>NCT03629353</nct_id>
  </id_info>
  <brief_title>The Efficacy of Transnasal Humidified Rapid-insufflation Ventilatory Exchange During Laryngeal Microsurgery</brief_title>
  <official_title>The Efficacy of Transnasal Humidified Rapid-insufflation Ventilatory Exchange in Patients Undergoing Laryngeal Microsurgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) was revealed to
      prolong apneic time with a slow increase in carbon dioxide; thus, has been used for
      preoxygenation in patients with difficult airways or requiring rapid sequence induction in
      general anesthesia.

      However, in patients undergoing hypopharyngeal and laryngo-tracheal surgery, THRIVE during
      operation can be advantageous by allowing tubeless surgical field with sufficient
      oxygenation.

      Therefore, the investigators conducted this study to evaluate the efficacy of THRIVE on
      prolonged apneic time with enhanced surgical conditions in patients with laryngeal
      microsurgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing laryngeal microsurgery will be randomized into either intubation group or
      THRIVE group.

      On arriving operating room, the patients will be preoxygenated by facemask or high flow nasal
      cannula with 100% oxygen for 3 minutes according to the allocated group. After inducing
      general anesthesia, patients in intubation group will be oxygenated by endotracheal tube,
      while patients in THRIVE group will be oxygenated by high flow nasal cannula with flow rate
      of 70L/min. During the surgery, the endotracheal tube can be removed and reintubated in
      intubation group patients to provide surgical field by a surgeon, respectively.

      The monitored pulse oximetry, oxygen reserve index, and transcutaneous partial pressure of
      carbon dioxide will be recorded during surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 17, 2018</start_date>
  <completion_date type="Anticipated">October 10, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lowest oxygen saturation</measure>
    <time_frame>from the time of starting laryngeal microsurgery till the end of the surgery</time_frame>
    <description>lowest oxygen saturation monitored by pulse oximetry during laryngeal microsurgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>lowest oxygen reserve index</measure>
    <time_frame>from the time of starting laryngeal microsurgery till the end of the surgery</time_frame>
    <description>lowest oxygen reserve index monitored during laryngeal microsurgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>highest transcutaneous partial pressure of carbon dioxide</measure>
    <time_frame>from the time of starting laryngeal microsurgery till the end of the surgery</time_frame>
    <description>highest transcutaneous partial pressure of carbon dioxide monitored during laryngeal microsurgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Apneic Oxygenation</condition>
  <arm_group>
    <arm_group_label>intubation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The enrolled patients will be oxygenated by endotracheal tube during operation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>THRIVE group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The enrolled patients will be oxygenated by intubationless high flow nasal cannula during operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>endotracheal intubation</intervention_name>
    <description>After preoxygenation with FiO2 1.0 and flow rate of 8 L/min for 3 minutes, the enrolled patients will be intubated with endotracheal tube and maintained oxygenation during surgery.</description>
    <arm_group_label>intubation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>high flow nasal cannula</intervention_name>
    <description>After preoxygenation with 100% oxygen through high flow nasal cannula for 3 minutes, the enrolled patients will be maintained intubationless oxygenation with flow rate of 70 L/min during surgery.</description>
    <arm_group_label>THRIVE group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing laryngeal microsurgery

          -  ASA class I-III

        Exclusion Criteria:

          -  patients scheduled for laryngeal microsurgery using CO2 laser

          -  patients with increased intracranial pressure

          -  patients with skull base defect

          -  patients with chronic obstructive pulmonary disease

          -  patients with pulmonary hypertension

          -  patients requiring rapid sequence induction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Youn Joung Cho, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Youn Joung Cho, MD</last_name>
    <phone>82-2-2072-2467</phone>
    <email>mingming7@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Se Hee Min, MD</last_name>
    <phone>82-2-2072-0779</phone>
    <email>seiheemin@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youn Joung Cho, MD</last_name>
      <phone>82-2-2072-3108</phone>
      <email>mingming7@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Se Hee Min, MD</last_name>
      <phone>82-2-2072-0779</phone>
      <email>seiheemin@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 9, 2018</study_first_submitted>
  <study_first_submitted_qc>August 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>September 6, 2018</last_update_submitted>
  <last_update_submitted_qc>September 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Youn Joung Cho, MD</investigator_full_name>
    <investigator_title>Clinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>airway management</keyword>
  <keyword>high flow nasal cannula</keyword>
  <keyword>laryngeal microsurgery</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

